BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2012

Feb 28, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2012-02-24

Reporting Person: BAFFI ROBERT (EVP, Technical Operations)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-02-24	Common Stock	M	16313	$6.13	Acquired	99806	Direct
2012-02-24	Common Stock	M	75000	$11.74	Acquired	174806	Direct
2012-02-24	Common Stock	S	91313	$34.8361	Disposed	83493	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-02-24	Stock Option (right to buy)	$6.13	M	16313	Disposed	2015-01-06	Common Stock (16313)	Direct
2012-02-24	Stock Option (right to buy) Common Stock	$11.74	M	75000	Disposed	2016-01-13	Common Stock (75000)	Direct

Footnotes

F1: The price in Column 4 is a weighted average price. The prices actually received ranged from $34.55 to $35.19. the reporting person will provide to the issuer, any security holder of the issuer, or SEC staff, upon request, information regarding the number of shares sold at each price within the range.

F2: Original option grant vested 6/48ths on July 7, 2005 and 1/48th on the 7th of every month thereafter.

F3: Original option grant vested 6/48ths on July 13, 2006 and 1/48th on the 13th of every month thereafter.